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Abstract: The concept of biphasic or multi-layered compound scaffolds has been explored within
numerous studies in the context of cartilage and osteochondral regeneration. To date, no system has
been identified that stands out in terms of superior chondrogenesis, osteogenesis or the formation
of a zone of calcified cartilage (ZCC). Herein we present a 3D plotted scaffold, comprising an
alginate and hydroxyapatite paste, cast within a photocrosslinkable hydrogel made of gelatin
methacrylamide (GelMA), or GelMA with hyaluronic acid methacrylate (HAMA). We hypothesized
that this combination of 3D plotting and hydrogel crosslinking would form a high fidelity, cell
supporting structure that would allow localization of hydroxyapatite to the deepest regions of the
structure whilst taking advantage of hydrogel photocrosslinking. We assessed this preliminary design
in terms of chondrogenesis in culture with human articular chondrocytes, and verified whether the
inclusion of hydroxyapatite in the form presented had any influence on the formation of the ZCC.
Whilst the inclusion of HAMA resulted in a better chondrogenic outcome, the effect of HAP was
limited. We overall demonstrated that formation of such compound structures is possible, providing
a foundation for future work. The development of cohesive biphasic systems is highly relevant for
current and future cartilage tissue engineering.
Keywords: cartilage tissue engineering; hydrogel; 3D plotting; hydroxyapatite; gelatin; alginate;
chondrocyte; chondrogenesis
1. Introduction
Articular cartilage is a complex tissue, organized into a zonal structure with varied biochemical
and biomechanical properties throughout each zone. Cartilage matrix is rich in collagens and
proteoglycans, with the dominant collagen type (>90%) being collagen type II [1]. The zones of
cartilage vary with depth, with collagen fiber orientation and chondrocyte morphology changing
throughout the tissue, from the superficial layer (fibers parallel to surface, flattened cell morphology),
to the transitional layer (fibers randomly oriented, rounded cell morphology) and finally the deep
layer (fibers perpendicular to surface, columnar cell alignment). The zone of calcified cartilage (ZCC)
is found beyond the deepest part of cartilage, linking the cartilage to the subchondral bone. The ZCC
varies considerably from the cartilage, for instance in collagen II content: ~60% dry weight in cartilage
versus ~20% in the ZCC [2]. Further, the percentage of hydroxyapatite (HAP) in the ZCC by dry weight
is ~65%, comparable with that of subchondral bone at ~86% [2]. The ZCC is also rich in collagen X,
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which is absent from hyaline cartilage [3]. It is overall a transitional tissue, providing a gradient of
mechanical properties between the more compliant articular cartilage and the stiffer underlying bone
tissue [3].
As intrinsic cartilage repair is poor, numerous strategies for regeneration have emerged, such as
the tissue engineering of cartilage scaffolds [4–7]. This approach predominantly revolves around
the use of hydrogels, highly hydrated and diffusive polymer matrices which provide nutrient
exchange and a three-dimensional (3D) matrix whilst also providing a desired chondromimetic
hypoxic environment [8,9]. 3D-printing/plotting has also been used in tissue engineering of cartilage
or osteochondral defects, wherein deposition of a polymer (melt or hydrogel) [10,11] and/or ceramic
paste (in the case of osteochondral scaffolds) [12,13] is used to form a mesh-type structure on a
computer-controlled stage, resulting in a scaffold structure with a desired morphology. Whilst hydrogel
matrices are highly suited to work towards cartilage regeneration, bridging the gap into engineering
full osteochondral defects is difficult and more complex [12].
Herein we focus on the development of a novel scaffold system constructed using a combination
of 3D plotting and gel casting with photopolymerization. Gelatin, commonly produced through
hydrolysis of extracellular matrix (ECM) collagens such as those found in bone and skin, retains
desired matrix metalloproteinase (MMP)-sensitive degradation sites and cell binding motifs such as
Arg-Gly-Asp (RGD) [14]. It is also chemically modifiable, yielding a photocrosslinkable hydrogel
gelatin methacrylamide (GelMA) [15]. Hyaluronic acid (HA), the most abundant glycosaminoglycan
(GAG) found in cartilage, is also similarly modifiable (hyaluronic acid methacrylate, HAMA) and
has been shown to promote chondrogenic differentiation in vitro [16]. In this work, we print grid
scaffolds made of an alginate/HAP paste to form a ZCC and combine these with a GelMA ˘HAMA
hydrogel system through ultraviolet (UV) photopolymerization. We hypothesize that such constructs
will ultimately be beneficial in innovation towards a complete osteochondral scaffold by entrapping
hydroxyapatite in proximity to chondrocytes and hence potentiating the development of a ZCC.
2. Experimental Section
Gelatin (G2500; ~300 g bloom), and methacrylic anhydride (MAAh, 276685) were purchased from
Sigma (Sigma-Aldrich, St. Louis, MO, USA). Hyaluronic acid (HA; molecular weight (MW) 0.86 MDa)
was purchased from Novozymes. 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone
(Irgacure 2959; IC) was purchased from BASF (BASF, Ludwigshafen, Germany). All quoted
concentrations in percent are weight per volume (% w/v) unless otherwise noted. Alginate (9005-38-3)
and methyl cellulose (9004-67-5 M0512, MW 88 kDa) were purchased from Sigma (Sigma-Aldrich,
Steinheim, Germany) and hydroxyapatite (1.02196.1000) was purchased from Merck (Darmstadt,
Germany). Hydroxyapatite particle size was previously quantified using Transmission Electron
Microscopy (TEM; F30, FEI, Zürich, Switzerland, operated at 200 kV), and found to comprise
needle-shaped particles with a length of 50 ˘ 4 nm and width of 17 ˘ 2 nm [17]. Calcium chloride
dihydrate (10035-04-8) was purchased from Roth (Karlsruhe, Germany).
2.1. Polymer Functionalization
Functionalization of gelatin (to gelatin methacrylamide, GelMA) and HA (to hyaluronic acid
methacrylate, HAMA), was performed as previously described [18,19]. Briefly, gelatin and HA were
dissolved in Milli-Q water (Merck Millipore, Billerica, MA, USA) at 10% and 1%, respectively. In the
case of gelatin, 0.6 g of MAAh per 1 g was added and reacted for 1 h at 50 ˝C [18]. HA was reacted with
a 5-fold molar excess of MAAh to hydroxyl groups for 8 h on ice, with pH monitored and adjusted
to 8 with 5 M NaOH [19]. After reaction, all gel solutions were subject to centrifugation to phase
separate and allow the removal of insoluble MAAh. HAMA was precipitated with ice-cold 100%
ethanol and collected, after which both were separately dialyzed against Milli-Q water to allow the
diffusion of any remainder of MAAh or methacrylic acid. After dialysis, GelMA was filtered through
0.2 µm filters (Merck Millipore) under aseptic conditions, pH adjusted to 7.4, lyophilized with 0.2 µm
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filters exclusively providing air exchange then stored at ´20 ˝C in sealed, sterile tubes. HAMA was
subject to the same processing apart from initial filtration to avoid macromer loss due to the large
molecular weight.
2.2. Degree of Functionalization
The degree of functionalization (DOF) of GelMA and HAMA was assessed using proton nuclear
magnetic resonance (1H NMR) spectroscopy. A Varian Direct Drive NMR spectrometer (Agilent
Technologies, Santa Clara, CA, USA) operating at 400 MHz for hydrogen, was used to record 1H
NMR spectra. All samples were dissolved at 1.0% in D2O at a temperature of 50 ˝C. Spectra were
recorded at an operational temperature of 50 ˝C, with 32 scans and a recycle delay of 30 s. For GelMA,
methacrylamide shifts were normalized against the aromatic signal of phenylalanine, at δ 7.4 ppm [20].
DOF was defined as the proportion of modified lysine groups of gelatin, as previously described
for collagen I methacrylamide [20]. The area obtained from the integral of intensities of the protons
present at the methacrylamide carbon-carbon double bond (IDB) occurring at δ 5.6 and 5.8 ppm was
normalized to proton number (nHDB ), and the area obtained from integrating the peak of the aromatic
groups (IA) was normalized to the protons interacting with the aromatic ring (nHA ). The prevalence
of modified groups and aromatic residues were then normalized to their prevalence by number in
porcine gelatin in order to allow for the quantitation of total methacrylamide to total possible lysine
groups (Equation (1)) [21]:
DOFGelMA p%q “
´
IDB
nHDB
¯
{% Lys´
IA
nHA
¯
{% Phe
(1)
For HAMA, chemical shifts were normalized against the signal from the N-acetyl group on the
HA backbone at δ 2.1 ppm [22]. The DOF, which in this case was defined as the fraction of modified
hydroxyl groups per repeating unit, was determined as previously described [22]. In brief, the average
area found from integrating the proton peak at the double bond (~δ 5.8 and 6.3 ppm; IDB) was
normalized to the number of protons at the double bond (nHDB ) and the area found from integrating
the proton peak of the N-acetyl group (ICH3 ) was normalized to the number of protons in the N-acetyl
group (nHCH3R ); the normalized double bond value was then divided by the normalized N-acetyl group
value to give the number of functional groups, which was assessed as a fraction of nOHM , the total
number of target reactive hydroxyl groups (4) present in a repeating monomer unit of HA, finally
resulting in the percentage of DOF, as illustrated below (Equation (2)):
DOFHAMA p%q “
IDB
nHDB
{ ICH3RnHCH3R
nOHM
ˆ 100 (2)
2.3. Hydroxyapatite/Alginate Scaffold Plotting
Pastes were made containing 42% (wt/wt) HAP, 1.74% (wt/wt) alginate and Milli-Q H2O
(for ALG/HAP scaffolds), and 10% (wt/wt) methyl cellulose, 1.74% (wt/wt) alginate and Milli-Q
H2O (for pure alginate (ALG) control scaffolds). An iterative process was used for the development
of the final paste composition, with the above blend of alginate and methyl cellulose providing
highest fidelity and structural integrity. Pastes were 3D plotted in air using a BioScaffolder 2.1 (GeSiM,
Großerkmannsdorf, Germany) into a 4 ˆ 4 ˆ ~0.5 mm grid using a 410 µm (inner diameter) needle,
with a printing speed of 3 mm¨ s´1. Extrusion pressure of 380 kPa and 250 kPa were used for ALG/HAP
and pure ALG scaffolds, respectively. A start-break (the application of pressure in advance of the
printing of a strand, i.e., during the approach of the nozzle to the designated start point) of 0.5 s was
used to ensure the initial region of each strand was printed with a stabilized flow. Further information
regarding printing parameters may be found in Kumar et al. [17]. Scaffold design consisted of 2 printed
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layers with 4 strands per layer. After plotting, scaffolds were stored in 1 M CaCl2 solution at 4 ˝C until
the day of cell encapsulation.
2.4. Micro-Computed Tomography Imaging
Micro-Computed Tomography (µCT) was used to qualitatively assess constructs containing ALG
and HAP (Scanco Medical µCT 40, operated at 55 kVp and 145 µA; Scanco Medical, Brüttisellen,
Switzerland), and determine HAP localization within the constructs.
2.5. Cell Isolation and Expansion
The full procedure for isolating chondrocytes is described elsewhere [23]. In brief, cartilage
samples were removed from macroscopically normal regions of the femoral condyle of a patient
undergoing full knee replacement surgery, with patient consent and ethical approval from the Prince
Charles Hospital and Queensland University of Technology (Ethics RM: 1400001024). After excision,
chondrocytes were cultured and expanded in low-glucose DMEM with 10% fetal bovine serum (Lonza,
Waverly, Australia), 2 mM glutamax, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), 0.1 mM non-essential amino acids (NEAAs), 0.5 µg¨mL´1 amphotericin B (Fungizone®;
Thermo Fisher Scientific, Waltham, MA, USA), 50 U¨mL´1 penicillin G sodium, 50 µg¨mL´1
streptomycin (all Invitrogen; Thermo Fisher Scientific, Waltham, MA, USA), 0.4 mM L-proline and
0.1 mM ascorbic acid (Sigma) and used at passage 3.
2.6. Hydrogel Formation and Culture
Stock solutions of GelMA, HAMA and IC were made in PBS on the day of gel formation.
Groups consisted of (Figure 1): 10% GelMA/ALG control scaffold (GelMA-ALG); 10%
GelMA/0.5% HAMA/ALG control scaffold (GelMA/HAMA-ALG); 10% GelMA/HAP scaffold
(GelMA-ALG/HAP); and 10% GelMA/0.5% HAMA/HAP scaffold (GelMA/HAMA-ALG/HAP).
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Figure 1. Schematic illustration of the groups included in the study.Groups used in the study
comprised (A): gelatin methacrylamide (GelMA) with an alginate (ALG) paste scaffold; (B): GelMA
with hyaluronic acid methacrylate (HAMA) with an ALG paste scaffold; (C): GelMA with a
combined alginate and hydroxyapatite paste (ALG/HAP) scaffold; and (D): GelMA/HAMA with an
ALG/HAP scaffold.
ALG and ALG/HAP 3D plotted scaffolds were placed into custom Teflon molds (50 ˆ 4 ˆ 2 mm
strips) and rinsed twice with DMEM to reduce calcium content from storage. Hydrogel precursor
solutions containing 0.05% IC were equilibrated at 37 ˝C for 15 min in an incubator. Chondrocytes at a
density of 106 mL´1 were added, and the mixtures were pipetted into the molds over the scaffolds
and covered with glass slides. Storage of 10 min at 4 ˝C was performed to allow GelMA to physically
crosslink, equilibrate groups, and minimize cell settling. UV crosslinking was done using 365 nm
light for a total energy of 1500 mJ¨ cm´2 (2.3 mW¨ cm´2 for 11 min) in a CL-1000 L crosslinker (UVP,
Upland, CA, USA). Cell-free groups were made in the same fashion, with cellular volume accounted
for in dilutions. After crosslinking, gel strips were cut to 4 ˆ 4 ˆ 2 mm and divided into 48-well
plates. After gels were divided, they were cultured for 28 days in chondrogenic differentiation
media (high-glucose DMEM with 2 mM glutamax, 10 mM HEPES, 0.1 mM NEAAs, 0.5 µg¨mL´1
Materials 2016, 9, 285 5 of 17
amphotericin B (Fungizone®; Thermo Fisher Scientific: Waltham, MA, USA), 50 U¨mL´1 penicillin G
sodium, 50 µg¨mL´1 streptomycin, ITS-G (100ˆ dilution; all Life Technologies), 1.25 mg¨mL´1 bovine
serum albumin (BSA), 0.4 mM L-proline, 0.1 mM ascorbic acid, 0.1 µM dexamethasone (all Sigma)
and 10 ng¨mL´1 transforming growth factor-β3 (TGF-β3; GroPep, Adelaide, Australia). Media was
changed three times a week.
2.7. Viability Assay
Viability was assessed on day 1 of culture (n = 3 samples per group). Gels were cut in half
and thereafter treated with fluorescein diacetate (FDA) and propidium iodide (PrI; both Invitrogen;
Thermo Fisher Scientific: Waltham, MA, USA) to stain live and dead cells, respectively. Gels were
rinsed twice in fresh PBS then incubated for 5 min at 37 ˝C in a 5 µg¨mL´1 FDA, 0.5 µg¨mL´1 PrI
PBS solution. Samples were imaged across the cross-section using fluorescence microscopy (Zeiss
Axio Imager M2; excitation: 488 nm and 568 nm, absorption 520 nm and 640 nm for FDA and PrI,
respectively—1.33 µm¨pixel´1). Quantification was performed using ImageJ software (National
Institutes of Health, New York, NY, USA). As chondrocytes were used in this study, culture plate
positive and negative staining controls were not used—the cells would be unable to recover a rounded
morphology in this setting and thus provide erroneous control data.
2.8. Mechanical Properties
Mechanical testing was performed on days 1 and 28 on cell-free and cell-containing samples
using an Instron MicroTester (Model 5848; Instron, Norwood, MA, USA). Each sample was
placed in a 37 ˝C PBS trough into which an aluminum plunger was submerged for unconfined
compressive displacement. The testing regimen consisted of a preliminary height measurement (∆force
(F) = ´0.01 N as height criterion), followed by a 0.5% strain (ε)/s (s) ramp to 16% ε for compressive
elastic modulus measurement. The value for elastic modulus was derived from the slope of the
stress-strain curve from 10% to 15% strain.
2.9. Biochemical Assays
Gels harvested on days 1 and 28 were disrupted by passing through a 19 G needle and digested
in 0.5 mg¨mL´1 Proteinase K solution, on a shaker plate overnight at 56 ˝C. The DNA content was
quantified using the Quant-iT™ PicoGreen® dsDNA assay kit (Invitrogen; Thermo Fisher Scientific:
Waltham, MA, USA) according to the manufacturer’s instructions.
GAG content of proteinase K-digested hydrogel and culture media samples were assessed using
the dimethyl-methylene blue (DMMB) assay (pH 1.5) (sample GAG on days 1 and 28, media on days
14 and 28). Absorbances at 525 and 590 nm were taken, with the ratio of the two absorbances
normalized to a chondroitin sulfate C (Sigma) standard to give the GAG content. All GAG content
measurements were normalized using cell-free constructs to account for GAGs released from the
hydrogels versus GAGs produced by the cells.
2.10. Gene Expression
RNA was extracted from constructs cultured for 28 days; gels were frozen at ´80 ˝C in 1 mL of
TRIzol reagent (Invitrogen; Thermo Fisher Scientific: Waltham, MA, USA), and RNA was extracted
according to manufacturer’s instructions. SuperScript™ III First Strand Synthesis System (Invitrogen;
Thermo Fisher Scientific, Waltham, MA, USA) was used to synthesize complementary DNA (cDNA).
DNase digestion was performed prior to cDNA synthesis and RNase digestion was performed after.
Primer sequences were either obtained from the literature for RPL13A, COL1A1, COL2A1,
ACAN and COL10A1 [9,24] or designed using Primer-BLAST (NCBI, Bethesda, MD) for TBP (5’Ñ3’
F:AGCCAAGAGTGAAGAACAGTC, R:CATCACAGCTCCCCACCATATT). Real-time quantitative
reverse transcriptase polymerase chain reactions (PCR) were performed in duplicates in a 7500 PCR
system (Applied Biosystems, Foster City, CA, USA) using SybrGreen Mastermix (Applied Biosystems/
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Invitrogen; Thermo Fisher Scientific: Waltham, MA, USA). The cycle threshold (CT) value of each
gene was normalized to the geometric mean of the housekeeping genes RPL13A and TBP using the
comparative CT method (2´∆CT).
2.11. Immunofluorescence
Gels from day 28 were frozen in Optimal Cutting Temperature compound (OCT, Sakura, Finetek,
Tokyo, Japan) and sectioned on a cryo-microtome at ´20 ˝C. Sections were fixed with ice-cold acetone
for 15 min, followed by antigen retrieval with 0.1% hyaluronidase (Sigma) for 30 min, which was
only included in the collagen I and II staining procedures. Primary antibodies were diluted in 2%
goat serum in PBS (Jackson ImmunoResearch, West Grove, PA, USA), and applied overnight at 4 ˝C
in a moist chamber. Antibodies for collagen type I (I-8H5, MP Biomedicals, Seven Hills, Australia,
1:300 dilution), collagen type II (II-II6B3, Developmental Studies Hybridoma Bank (DSHB), Iowa
City, IA, USA, 1:200 dilution), collagen type X (14-9771-82 Clone X53, Jomar Bioscience Pty Ltd.,
Kensington, Australia, 1:300 dilution), aggrecan (969D4D11, Life Technologies 1:300 dilution) or
isotype controls (mouse IgG, Jackson, 1:1000) were used. Subsequently, sections were incubated in 2%
donkey serum/PBS with IgG1-specific AlexaFluor®488-labelled goat anti-mouse secondary antibodies
and IgG2a-specific AlexaFluor®594-labelled goat anti-mouse secondary antibodies (Jackson 1:150) and
5 µg¨mL´1 4’,6-diamidino-2-phenylindole (DAPI, Sigma) for 1 h at room temperature. Images were
captured with fixed exposure times on a Zeiss Axio Imager M2 microscope with epi-fluorescence
attachment (Carl Zeiss, Jena, Germany).
2.12. Statistical Analyses
Analysis of Variance (ANOVA) tests were used to assess differences between groups, with Tukey’s
post-hoc tests used to determine inter-type relationships in groups with equal variances assumed
(e.g., cell-free constructs); Dunnet’s T3 post-hoc test was used for cell-containing samples, assuming
unequal variances. Tests were conducted using SPSS 21.0 (IBM Corporation: Armonk, NY, USA) with
p-values < 0.05 regarded as significant. Figure bars show mean ˘ standard deviation. Captions state
where independent sample t-tests were used instead of ANOVA. Statistically significant differences are
indicated using Roman numerals or symbols; any groups sharing a Roman numeral are statistically
similar whilst groups without a like numeral are different.
3. Results
3.1. Scaffold Manufacturing by 3D Plotting
Scaffolds were successfully fabricated using the BioScaffolder 2.1 and remained intact from
day 1 (Figure 2A) to day 28 of culture (Figure 2B). Visualization of scaffolds in combination with
gels was done using µCT and confirmed localization of hydroxyapatite to the deep region of the
construct (GelMA-ALG Figure 2C, GelMA-HAP Figure 2D). Four groups were chosen for the
study (Figure 1), comprising HAP-containing (GelMA-ALG/HAP, GelMA/HAMA-ALG/HAP) and
HAP-free (GelMA-ALG, GelMA/HAMA-ALG) constructs.
3.2. Degree of Functionalization
To form photocrosslinkable polymers, gelatin and hyaluronic acid were functionalized using
varied molar excesses of MAAh. 1H NMR analysis was performed to obtain DOF from NMR spectra
(Figure 3). GelMA was found to be 76.2% functionalized, and HAMA was 25.0%.
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Figure 2. Images of hydrogel/scaffold hybrid constructs. (A) photo illustrating ALG/HAP scaffolds
crosslinked within GelMA hydrogels on day 1 and (B) day 28. Scale bar 4 mm; (C,D) scaffolds imaged
using micro-computed tomography (µCT), with thresholding used to isolate high density components
(colored scale illustrates mg¨ cm´3 of HAP); (C) GelMA-ALG and (D) GelMA-ALG/HAP illustrated,
scale bar 1 mm as indicated.
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Figure 3. Proton Nuclear Magnetic Resonance (1H NMR) spectra of hydrogels. (A): gelatin; (B): gelatin
methacrylamide (GelMA); (C): hyaluronic acid (HA); (D): hyaluronic acid methacrylate (HAMA). Areas
of interest are inset withi each frame. Aromatic peaks in gelatin/GelMA are r sent at ~chemical
shift (δ) 7.4 ppm, with the two free protons on the methacrylate groups present at δ 5.6 and δ 5.8 ppm
respectively. In HA, the peak from th N-acetyl protons is present at ~δ 2.1 ppm, with the methacrylate
protons used for degree of functionalization (DOF) measurements present in HAMA at δ 5.8 and
δ 6.3 ppm.
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3.3. Viability
Live/dead staining was performed using FDA (live) and PrI (dead) to assess cytotoxicity of the
scaffolds or the hydrogel system. No abnormal cytotoxic effects were detected from scaffolds on day
1 of culture in any group (Figure 4A–D), with no significant difference between quantified scaffold
viability (Figure 4E; n = 3 samples per group). A viability of 80% is an expected value considering
chondrocyte expansion, encapsulation and processing through UV radical polymerization.
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3.4. Mechanical Properties
Mechanical testing was performed on cell-free and cell-containing (human articular chondrocytes,
HAC) constructs to assess purely material-based stiffness as well as stiffness due to ECM deposition
throughout culture. Elastic modulus was found to be slightly h gher in cell-free HAP groups (Figure 5A;
n = 3 per group), with significant difference only observed between GelMA-ALG, GelMA/HAMA-ALG
and GelMA/HAMA-ALG/HAP on day 1. On day 28, difference was noted between GelMA-ALG and
GelMA/HAMA-ALG/HAP. Modulus of cell-free constructs did not increase during culture, which
ensured changes in cell-containing gels were cell-mediated. Cell-containing gels (Figure 5B; n = 3 per
group) were not significantly different on day 1, but all significantly increased over the culture period.
It was found that GelMA-ALG (~50 kPa) was significantly lower than GelMA/HAMA-ALG (~65 kPa),
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with the two HAP groups significantly higher than the ALG control groups but statistically similar to
each other (GelMA/ALG-HAP: ~77 kPa, GelMA-HAMA/ALG-HAP: ~85 kPa).
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Figure 5. Mechanical testing results showing compressive elastic modulus. Elastic modulus of samples
on days 1 and 28 of culture (n = 3 per group) with (A): cell-free and (B): cell-containing gels shown
separately. The four groups in each time point were compared separately to the second time point,
with upper case Roman numerals used for day 1 and lower case for day 28. When groups share Roman
numerals they are statistically similar. Bars with stars indicate t-test comparison results between one
group across two time points.
3.5. DNA and GAG Content
easurements of DNA content and GAG content were performed on all construct groups, with
GAG content in media also measured. In all cases cell-free constructs were used to correct for any
material-based content potentially interfering with the GAG measurements. These data were collected
to illustrate whether there were proliferative differences between groups (DNA content), and to assess
chondrogenesis (GAG content). Normalization of GAG content to DNA content was done to account
for cell number skewing raw GAG content per wet weight data. Large increases in GAG content
per wet weight were observed between days 1 and 28, with all groups increasing from between
5- and 8-fold (Figure 6A). GAG content per wet weight in the GelMA-ALG and GelMA-ALG/HAP
groups were significantly different to the GelMA/HAMA-ALG and GelMA/HAMA-ALG/HAP
groups, however no differences were found between ALG and ALG/HAP within each gel blend.
Overall, HAMA appeared to have a positive effect on chondrogenesis during culture. The DNA
content in constructs increased slightly over the culture period, which showed that cellular activity
was maintained (Figure 6B). GAG content per DNA content data shared the same trends as GAG
content per wet weight, as would be expected with stable DNA levels throughout the culture and
between groups (Figure 6C). GAG content per media was found to be consistent between day 14 and
day 28, indicating that a similar low level of GAG was lost to the media throughout culture (Figure 6D).
Sample size of n = 3 per group was used in all cases.
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3.6. Gene Expression
Analysis of gen expression was f r ed to test the ffects of m terials on gen expression
in the syste . COL2A1 and ACAN levels were tested to assess positive chondrogenesis, with
COL1A1 and COL10A1 serving as indicators for fibrocartilage development and chondrocyte
hypertrophy/calcification. Gene expression results showed an influence of HAMA, with a decrease
in COL1A1 (Figure 7A), increase in COL2A1 (Figure 7B), increase in ACAN (Figure 7C) and decrease
in COL10A1 (Figure 7D) in HAMA-containing gels. Whilst some slight variability existed within
HAMA-free and HAMA-containing gels, no significant difference was detected with the presence
of HAP.
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3.7. Immunofluorescence
Immunofluorescence was conducted on sections to corroborate gene expression data on an
ECM-protein level. Staining was done for collagen I and II (I red, II green, Figure 8A–D), aggrecan
(Figure 8E–H) and collagen X (Figure 8I–L) performed on all groups (top row: GelMA-ALG, second
row: GelMA/HAMA-ALG, third row: GelMA-ALG/HAP, bottom row: GelMA/HAMA-ALG/HAP).
Chondrocyte spreading and high collagen I expression was clearly observable at the surface of the
gels compared with the interior. Within the center of the gels a chondrogenic response was confirmed
through a more rounded chondrocyte morphology and collagen II staining. Aggrecan staining was
found throughout the matrix of all groups as well as at the surface. Collagen X appeared present
throughout the ECM, with strongest staining apparent at the HAP interface (as seen in the lowest
area of panel K). Images were taken of the deep portion of hydrogels at the periphery of the scaffold
meshes, with surface images inset. Overall a chondrogenic effect of HAMA was observed, with a
very limited influence of HAP. Isotype negative controls in the form of mouse IgG were used to assess
non-specific staining (data not shown).
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P, A-ALG/HAP) and P-free l - ,
HAMA-ALG) f l were produced through 3D plotting of alginate or alginate/
hydroxyapatite p ste and photocrosslinked with hy rogels to form hybrid constructs f r evaluati n
of preliminary osteochondral regene tion. Whilst hydrogels wid y appear to give the most
desire matrix in erms of hypoxia, high fluid content, ease of diffu ivity and tailorable mechanical
properties, there is no clear consensus on what type of material is most d s rable for ost ochondral
reg neration [13,25–29]. Herein we pres nted a hybrid construct containing both cho dro- and
osteo-c nductive materials. However, it is a pr liminary desig which does not afford the clear
materi l-driv n effects we may observe when using homogeneous structures. Khanari and
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colleagues present such a construct, showing that in a large volume scaffold with a homogenous
composition, the potential of hydroxyapatite as a ZCC material is clearly shown [27]. In this study,
alginate was used as the hydrogel component of the ceramic/hydrogel scaffold, although unlike in
our study, the construct was not formed using 3D plotting. Alginate has previously been shown to be
both supportive of chondrocytes in culture [30–32], and valid as a tissue engineering vessel [33–35]. It
also has desirable viscous properties for 3D plotting and ionic crosslinking capabilities that allow for a
rapid sol-gel transition. Furthermore, alginate has been shown to be biocompatible and biodegradable,
supportive of native chondrocyte morphology and matrix deposition, as well as promoting bone
healing in certain cases [36,37]; all of which led to our selection of alginate as a component of our
ceramic paste. Our team has also recently published work involving a somewhat similar concept to the
plotting mechanism presented herein, finding that 3D plotting of gelatin/alginate with or without HAP
was an efficacious scaffold system, supporting bone marrow stromal cells over 21 days in vitro [38].
Interestingly, the limited chondrocyte hypertrophy we observed (as evidenced by COL10A1
expression and immunofluorescent staining) was similar for Khanarian et al. [27], who reported that
the exclusive use of deep zone chondrocytes gave a much better result in terms of hypertrophy and
mechanical properties when compared with full thickness cells. It may be inferred that subdividing
constructs in the future to isolate cell populations may be advantageous. For instance, the calcified
layer of the scaffold may be printed with cells included within the paste, and/or a small layer of
hydrogel containing deep zone chondrocytes may be photocrosslinked onto the mesh, followed by
a layer of hydrogel containing superficial or full thickness chondrocytes for the remainder of the
construct. Alternately, the printing of the entire construct may be possible if appropriate material
optimizations are performed to ensure structural fidelity. Whilst the material choice is supported
by literary evidence and conducive to chondrogenesis, there is a limited effect on calcification that
indicates the scaffold system requires further development and characterization.
Use of layered constructs has been explored extensively in the literature, with three main
methods used: (1) seeding of chondrocytes or neocartilage tissue directly onto a bone scaffold;
(2) “assembling” a bilayered scaffold from two components; and (3) forming an “integrated” bilayered
scaffold [39]. Our approach falls into category 3, and is also supported in principle and material
choice (alginate) by a study focused on 3D plotting of layered scaffolds, where preliminary outcomes
show chondrogenesis both in vitro and in vivo [13]. Data related to enhanced mechanical properties
also reinforce the relevance of this work, with Hollenstein et al., showing improved bone-hydrogel
interfacing when a ZCC was included in constructs [25]. Whilst all the aforementioned studies delve
into innovations within this field, the fact remains that further study is required in order to completely
construct a relevant picture of what is required for successful osteochondral regeneration through
the implementation of scaffold technologies. Namely, it is difficult to determine which chondrogenic
and osteogenic components are most efficacious for the regeneration of a single component. In a
combined environment, it is also difficult to determine whether their applicability to the regeneration
varies upon combination or is affected by a biphasic system. In our approach we used a chondrogenic
medium containing transforming growth factor (TGF)-β3. It has been shown that TGF-β3 is involved
in both chondrogenic [40] and osteogenic [41,42] differentiation, and hence it was considered as
conducive to development in both areas of our construct. Future studies may benefit from an alternate
culture approach however, as TGF-β3 has been shown to decrease scar tissue formation through the
attenuation of collagen type I synthesis; however these effects are largely demonstrated on skin lesions
postoperatively and hence in fibroblastic cells [43–45]. Its effects on collagen type X synthesis are
currently undefined and conversely to the above, it has also been observed to stimulate transcription
of the COL1A2 gene [46]. Hence the level to which it may be influential on the development of the
ZCC are yet undetermined and require further testing.
Overall, in this study we presented a preliminary structure consisting of a mesh scaffold combined
with a hydrogel polymer, and show that the combination yields a greater increase in mechanical
properties than that of a control scaffold (ALG), and that the use of the ALG/HAP scaffolds does
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not negatively influence chondrogenic response of chondrocytes in vitro. Limited cytotoxicity was
observed on day 1 from either of the two scaffold types or the gels, as confirmed by fluorescent
staining and subsequent image quantification. While viability was not assessed at later time-points,
increases in DNA and GAG content indicated that cells remained viable throughout the entire
28 day culture period. Elastic modulus increased considerably throughout the culture period, with
HAMA significantly increasing modulus in ALG groups and the use of ALG/HAP scaffolds increasing
modulus relative to the ALG groups. It may be reasoned that the addition of hyaluronic acid within
the hydrogel positively influenced both the cell activity throughout the culture period, as well as
providing an additional material that is able to crosslink to both its own and to the gelMA network.
There was an increased trend in modulus with ALG/HAP, which may be due to the significantly
higher density in the scaffold. Scaffold strands were printed with the same diameter nozzle in both
cases (ALG and ALG/HAP) and hence with the HAP groups a lesser proportion of water was present
in each strand. The HAP content was in fact 42%, and hence the concentration of alginate in water
would also be higher in the ALG/HAP scaffold strands compared with the ALG alone. However,
simultaneously the alginate network integrity may be disturbed by the presence of HAP particles
within the construct strands, and any benefit to the increased concentration of ALG within the strand
may be mitigated. Finally, if indeed the ALG/HAP scaffold matrix was stiffer than ALG, the increase
in overall construct modulus may be caused by a lesser transverse expansion of the scaffolds under
load. This hypothesis is supported by Khanarian et al. [27], who demonstrate an increase in modulus
of scaffold constructs made entirely from alginate and hydroxyapatite, and hence it may be concluded
that the presence of the HAP does in fact influence the stiffness of the construct strands. The mechanical
properties obtained herein are over an order of magnitude lower than that of native cartilage tissue,
however the mimicry of native values may be not required. The construct must of course be able to
withstand the mechanical environment of the joint, but with appropriate stimulus (driven through
the neotissue matrix) the matrix deposition of chondrocytes may be encouraged. As this model was
cultured in a static environment, the values of modulus are not representative of what would be
attainable under compressive loading during culture. This was done however to simplify the process
and allow the examination of parameters in a less complex system. It is unclear what mechanical
properties are ideal for a tissue engineered cartilage construct, however it is the belief of the authors
that this will become clearer as biomaterials research progresses.
Examination of GAG and DNA content within the scaffolds showed consistent DNA levels
between groups, and a comparable yet significantly different level of GAG secreted between the gelMA
and the gelMA/HAMA groups. In all cases HAMA increased the level of GAGs produced, yet the
varying of scaffold type from ALG to ALG/HAP failed to have an effect on this metric. It may be that
the localization of the scaffolds to the greatest depth of the gels along with their physiologically relevant
thickness reduces any potential effects they may have on the majority of the chondrocytes within the gel
phase. However, it is clear that inclusion of a prominent glycosaminoglycan such as HA within the gel
has a positive effect on chondrogenic differentiation, whilst it is unknown what effect methacrylation
of this compound has on its cellular interactions. This data confirms our research group’s previous
findings, where HAMA was found to be supportive of chondrogenic differentiation [16]. As all GAG
data were corrected using cell-free constructs, the influence of HAMA on the GAG assay was negated.
PCR data showed a much higher expression of COL1A1 and COL10A1 in the HAMA-free gels,
indicating a fibrocartilaginous phenotype, whilst COL2A1 and ACAN expression further supported this
conclusion. Higher levels of collagen I and collagen X are indicative of dedifferentiated chondrocytes,
with elevated levels observed in gelMA-only gels throughout the literature [16,47]. This effect is
namely due to the high number of attachment (RGD peptide) sites present on gelatin that strongly
promote cell attachment and hence spreading, along with the fact that the polymer is a derivative of
largely collagen type I.
Higher expression levels of chondrogenically relevant genes such as COL2A1 and ACAN were
observed in HAMA-containing gels compared against HAMA-free groups. There was no significant
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effect of ALG/HAP scaffolds on COL10A1 expression, although a slight trend was noticeable. It
is possible that downregulation of COL1A1 and COL10A1 in hydrogels containing HAMA was
caused by activation of CD44, as in low concentrations hyaluronic acid has been shown to promote
chondrogenesis through this pathway [48,49]. Immunofluorescence examining protein levels in the
matrix indicated similar relationships to PCR, with higher collagen I staining found in HAMA-free
gels and stronger collagen II and aggrecan staining observable in HAMA-containing gels. Collagen
X staining appeared relatively even throughout the ECM, with gelMA-ALG/HAP showing staining
surrounding the lowest region of the scaffold which was the area of interest in this case (Figure 8K).
The levels in all groups did not vary enough to show conclusive effects, however trends appeared to
support PCR findings and hence are also explainable and in support of the previously listed reasoning.
In all cases isotype negative controls consisted of mouse IgG and verified no non-specific staining of
matrix occurred.
In line with previous results [25,27,50], we found a slight increase in modulus after culture of
ALG/HAP scaffolds, with comparable trends in cell free conditions. On the other hand, whilst others
have shown that inclusion of bioactive glass increases GAG in hydrogels [28], we found ALG/HAP to
have a limited effect in our system. As the ALG/HAP scaffolds were intact at the time of crosslinking
and appeared to remain intact at day 28 of culture, it may be postulated that limited diffusion of HAP
occurred throughout the culture period. It may thus be inferred that culture in a system such as a
compression bioreactor may further accentuate the observed trends and bring them to a significant and
notable level. With appropriate structural modifications, perfusion bioreactors may also be suitable for
this application [36]. Overall we showed that the combination of gelMA and HAMA with a HAP/ALG
scaffold system is viable for cells, maintains positive chondrogenesis and provides a platform for the
exploration of innovation into such scaffold technologies.
5. Conclusions
Scaffolds comprising human articular chondrocyte-containing hydrogels (GelMA or
GelMA/HAMA) crosslinked through 3D printed paste meshes (alginate or alginate/HAP) were
cultured for 28 days under chondrogenic conditions in vitro. No cytotoxicity was observed from
scaffold components. Incorporation of HAMA into hydrogels improved chondrogenesis. The use of
ALG/HAP versus ALG did not encourage the formation of a ZCC, however changes in scaffold design,
such as incorporation of a larger amount of HAP, or use of bioreactor systems may be used in the
future to expand on this system.
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